A contemporary standard for morbidity and outcome after radical cystectomy

BJU International

Volumn 104, Issue 5, 2009, Pages 628-632

  Ramani, Vijay A C ^a   Bromage, Stephen J ^a   Clarke, Noel W ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Contemporary standard; Cystectomy; Exenteration; Mortality

Indexed keywords

ANTINEOPLASTIC AGENT;

ABSCESS; ADULT; AGED; ANALYSIS; ANASTOMOSIS DEHISCENCE; ANESTHESIST; ANUS TUMOR; ARTICLE; BLADDER TUMOR; BLEEDING; BOWEL LEAKAGE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEST INFECTION; COLON TUMOR; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CYSTECTOMY; ENTEROPATHY; FEMALE; FISTULA; HEALTH CENTER; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HUMAN TISSUE; ILEUS; INCISIONAL HERNIA; INTESTINE OBSTRUCTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; METABOLIC DISORDER; MORBIDITY; OUTCOME ASSESSMENT; PATHOLOGY; PELVIS EXENTERATION; PERIOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; RECTUM TUMOR; REOPERATION; RESPIRATORY FAILURE; RISK FACTOR; SURGICAL MORTALITY; TREATMENT OUTCOME; URETER DISEASE; URETER OBSTRUCTION; URETER PROLAPSE; URETER RETRACTION; URETER STRICTURE; URETEROILEAL STRICTURE; URINARY TRACT INFECTION; URINE INCONTINENCE; UTERINE CERVIX TUMOR; UTERUS TUMOR; VAGINA TUMOR; VULVA TUMOR; WOUND INFECTION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; PELVIC EXENTERATION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SALVAGE THERAPY; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 68849118132     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08506.x     Document Type: Article

References (14)

1. Herr H, Dotan Z, Donat SM, Bajorin DF. Defining optimal therapy for muscle invasive bladder cancer. J Urol 2007 177 : 437 3
2. Bredin HC, Prout GR Jr. One-stage radical cystectomy for bladder carcinoma: operative mortality, cost/benefit analysis. J Urol 1977 117 : 447 51
3. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long term Results in 1054 patients. J Clin Oncol 2001 19 : 666 75
4. Novotny V, Hakenberg OV, Wiessner D et al. Perioperative complications of radical cystectomy in contemporary series. Eur Urol 2007 31 : 397 402
5. Chahal R, Sundaram SK, Iddenden R, Forman DF, Weston PM, Harrison SC. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire. Eur Urol 2003 43 : 246 57
6. Madersbacher S, Hochreiter W, Burkhard F et al. Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003 15 : 690 6
7. Thrasher JB, Frazier HA, Robertson JE, Dodge RK, Paulson DF. Clinical variables which serve as predictors of cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 1994 15 : 1708 15
8. Boström PJ, Kössi J, Laato M, Nurmi M. Risk factors for mortality and morbidity related to radical cystectomy. BJU Int 2008 July 29. [Epub ahead of print]
9. Stroumbakis NM, Herr H, Cookson MS, Fair WR. Radical cystectomy in the octogenarian. J Urol 1997 158 : 2113 7
10. Hollenbeck BK, Miller DC, Taub D et al. Identifying risk factors for potentially avoidable complications following radical cystectomy. J Urol 2005 174 : 1231 7
11. Rosario DJ, Becker M, Anderson JB. The changing pattern of mortality and morbidity from radical cystectomy. BJU Int 2000 85 : 427 30
12. Nieuwenhuijzen JA, Horenblas S, Meinhardt W, van Tinteren H, Moonen LM. Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer. BJU Int 2004 94 : 793 7
13. Chang SS, Cookson MS, Baumgarten RG, Wells N, Smith JE. Analysis of early complications after radical cystectomy: Results of a collaborative care pathway. J Urol 2002 167 : 2012 6
14. Joudi FN, Konety BR. The impact of provider volume on outcomes from urological cancer therapy. J Urol 2005 174 : 432 8